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Four mathematical models for the study of the disease transmission dynamics of tuberculosis (TB) are 
presented. We also discuss issues related to optimal vaccination strategies for TB. A two-strain TB model 
is formulated to determine possible mechanisms for the survival and spread of naturally resistant strains of 
TB as well as antibiotic-generated resistant strains of TB. Analysis of this model shows that non-antibiotic 
co-existence is possible but rare for naturally resistant strains while co-existence is almost the rule for strains 
that result from the lack of compliance with antibiotic treatment by TB infected individuals. A distributed 
delay model is used to look at the effects of long and variable periods of latency on the dynamics of TB. 
We use a third model to show that exogenous reinfection has a drastic effect on the qualitative dynamics of 
TB. Finally an age-structured model is used to determine optimal vaccination strategies for TB. We only 
outline our results in this short article. 
1. Introduction. Tuberculosis is a bacterial disease with an astimated one third of the 
world human population as its reservoir. The disease is most commonly transmitted from 
a person suffering from infectious (active) tuberculosis to susceptible (and possibly latently 
infected) persons by infected droplets created when the person with active TB coughs 
or sneezes. Among generally healthy persons, infection with TB is highly likely to be 
asymptomatic. Data from a variety of sources suggest that the life time risk of developing 
clinically active TB after being infected is approximately 10% (Hopewell1994). Individuals 
who have a latent TB infection are not clinically ill nor capable of transmitting TB (Miller 
1993). At greater ages, the immunity of persons who have been previously infected may 
wane, and they may be then at risk of developing active TB as a consequence of either 
exogenous reinfection (i.e., acquiring a new infection from another infectious individual) 
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or endogenous reactivation of latent bacilli (i.e., re-activation of a pre-existing dormant 
infection) (Styblo 1991, Smith 1994). 
Latent and active TB can be treated with antibiotics. However, its treatment has side 
effects (sometimes quite serious) and takes a long time. Carriers of the tubercle bacillus 
who have not developed TB disease can be treated with a single drug INH; unfortunately, 
it must be taken religiously for 6-9 months. Treatment for those with active TB requires 
the simultaneous use of three drugs for a period of at least 12 months. Lack of compliance 
with these drug treatments (a very serious problem) not only may lead to a relapse but to 
the development of antibiotic resitant TB - one of the most serious public health problems 
facing society today. 
In the United States, the estimated total number of TB infections lies between 10-15 
million persons (Miller 1993). However, dramatic increases in the incidence of TB (new 
cases per year) have occurred within the United States over the past few years. From 1985 
to 1991, the number of reported cases of TB has increased 18% with 26,283 cases reported 
in 1991 (Kent 1993). Outbreaks of drug resistant TB in the United States have begun 
to alarm doctors and public health officials. Over 80% of the patients in these outbreaks 
have died, often within weeks of being diagnosed as having tuberculosis. These problems 
are compounded by economics, as the cost of treating a patient with MDR-TB can exceed 
$250,000: nearly 100 times the cost of treating most other TB cases (Press release WHO 
/89 Nov. 1994). The emergence of the HIV epidemic has dramatically increased the risk of 
developing clinical TB in infected persons and it has contributed to the observed dramatic 
increase of TB rates globally. 
A TB vaccine called BCG (Bacillus of Calmette and Guerin) has been available 
for many decades but its effectiveness in preventing TB is con~roversial (Salyers 1994). 
Results of field trials of the vaccine have differed widely, some indicating protection rates 
as high as 70% to 80% while others showing as a completely ineffective vaccine for the 
prevention of TB. 
Many mathematical models have been developed to study communicable diseases such 
as measles, influenza, rubella, and chicken pox (see Hethcote 1976, Dietz 1979, Hethcote, 
Stech, and van den Driescsche 1981, Anderson 1982, Anderson and May 1982, 1991, Dietz 
and Schenzle 1985, Dietz 1985, Anderson and May 1983, Schenzle 1984, Hethcote and Van 
Ark 1987, Castilla-Chavez et al. 1988, 1989, Feng 1994, Feng and Thieme 1995). These 
infectious diseases have several features in common for example, they cause recurrent epi-
demic outbreaks and transmission rates depend strongly on age-dependent contact rates. 
The etiological agents of these communicable diseases are viruses from different families 
but all capable of generating similar epidemiological responses at the level of the indi-
vidual (symptoms). Common responses include relatively short latent periods, followed 
by also relatively short infectious periods and permanent immunity after recovery. It is 
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not completely clear when individuals become infectious (that is, capable of transmitting 
the disease) as some may become infectious while symptomless. The situation of TB de-
spite its fundamental role in the development of bacteriology and modern epidemiology is 
paradoxically different. The study of the spread of TB using statistical and mathematical 
models has not received enough attention. In fact we have observed only an extremely 
limited use of mathematical models in the study of the transmission dynamics of TB in 
human populations. 
In this paper we formulate a series of mathematical models to study the dynamics of 
TB. We use a system of ODE's to study the role that lack of drug treatment compliance 
by TB patients plays on the maintenance of antibiotic resistant strain. A distributed delay 
model is used to study the effect of the long and variable latency periods in the progression 
of TB on the disease dynamics. We also use a simple system of ODE's to assess the 
role of "reinfection" in the development of active TB. We construct an age-structured TB 
model to explore· possible optimal vaccination strategies for TB. In the following section 
we present a series of models for the transmission of TB and some results. Section 3 is 
devoted to the conduction of numerical simulations that support or complete some of our 
analytical results. Section 4 collects our thoughts and conclusions. 
2. TB models. We basically divide the host population into the following epidemi-
ological classes or subgroups: Susceptible (8), Latent (L, infected but not infectious), 
Infectious (I), and (effectively) Treated (T) individuals. N is used to denote the total 
population. We assume that an individual may be infected only through contacts with 
infectious individuals. We also assume that treated individuals can become infected again. 
2.1. A two-strain TB model. Consider two trains of TB: the regular TB (strain 1) 
and the resistant TB (strain 2). Let L1 and L2 denote latent with strain 1 and strain 2, 
respectively. I and J stand for infectious with strain 1 and 2. Using Fig. 1 we can write 
the following system of ordinary differential equations: 
(1) 
.!!:._8 =A- (3c8!_- {3*c8!_- p,S 
dt N N 
d I ( ) (3' I * J dt Lt = (3c8 N - f..L + k L1 - r1L1 + pr2I + cT N - (3 cL1 N 
d 
dt I = kL1 - (f..L + d)I - r2I 
d ( ) (3' I (3* J 
-T = r 1L 1 + 1- p- q r2I- cT-- cT-- p,T & N N 
!!__L2 = qr2I- (f..L + k')L2 + (3*c(8 + Lt + T)NJ dt 
!1 = k'L2 - (f..L + d')J 
N = 8 + L 1 +I+ T + L2 + J. 
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A is the recruitment rate; f3 and /3' are the average proportions of susceptible and treated 
individuals infected by one infectious individual per contact per unit of time, respectively; 
f3* is the average proportion of individuals infected by one resistant-TB infectious individ-
ual per contact per unit of time; c is the per-capita contact rate; 1-L denotes the per-capita 
natural death rate; k and k' are the rates at which individuals leave the latent classes 
L1 and L2, respectively, by becoming infectious; d and d' stand for the per-capita disease 
induced death rates by strains 1 and 2; and r1 and r2 are the per-capita treatment rates for 
(regular TB) latent and infectious individuals, respectively; p+ q is the total proportion of 
those treated infectious individuals who did not complete their treatment. The proportion 
p modifies the rate that departs from the latent class; qr21 gives the rate at which indi-
viduals develop resistant-TB because they did not complete the treatment of active TB. 
We assumed that the treatment rate for resistant TB individuals is very small and can be 
neglected. 
The basic reproductive numbers for the two strains (natural and resistant) are given 
by 
and 
( f3*c ) ( k' ) R2= p,+d' p,+k'' 
respectively. We can interpret R1 and 1?,2 as the average numbers of secondary infectious 
cases produced by an ordinary TB strain and one resistant-TB infectious individual during 
his or her effective infectious period, respectively. 
If we let 
then ~ = 1 gives a threshold condition in the sense that the disease will die out if ~ < 1 
while the disease may become endemic if Ro > 1. 
Next we consider the case when the infection probability per contact for the treated 
class is the same as that of the susceptible class, i.e., /3' = /3. There are four possible 
equilibrium points: the disease free equilibrium Eo; two boundary equilibria 
E 1 (when only the first strain is present); E2 (when only the second strain is present); 
and the interior equilibrium E* (when both strains present). 
To conduct an analytical analysis of asymptotical behaviors of the equilibria we assume 
that there is no disease-induced death rate, i.e., d = d' = 0. For d > 0 and d' > 0 our 
numerical simulations support similar results (see Section 3). Hence we have that 
d -N=A-~~N dt ,..- ' 
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and, consequently, N(t) -7 A/ p, as t -7 co. Without loss of generality (see Thieme 1992, 
1994) we assume that our population has reached its limiting value, i.e., 
N = A/ p, = S + T + L1 +I+ L2 + J. 
Introducing the fractions 
J 
Yz= N' 
and using {3' = {3, we can eliminate the equations for S and T and replace S + T by 
N- £1 -I- L2 - J to obtain from (1) the equivalent limiting system (Thieme 1993) 
! x1 = {3c(1 - x1 - xz - Y1 - Y2)xz - (fl + k + r1)x1 + przx2 - {3* c:x1Y2 
d 
dt x2 = kx1 - (p, + rz)x2 
!Y1 = qrzx2- (fl + k')Y1 + f3*c(1- X2- Y1- Yz)Yz 
(2) 
d I 
dtYz = k Y1 - flYz· 
With this notation, we are able to setablish the following result: 
Result 1 Assume that q = 0, d = d' = 0. Then 
(a). The disease-free equilibrium Eo of System (2) is g.a.s. if'Ro < 1, i.e., if'R-1 < 1 
and 'R-2 < 1. 
(b). H'R-1 > 1, then there exists a threshold curve given by the function f('R-1) such 
that the boundary equilibrium E1 of (2) is l.a.s. if'R-z < /('R-1) and unstable if'R-2 > f('R-1). 
Moreover, j('R-1) > 1 for all 'R-1 > 1 and /(1) = 1. 
(c). If 'R-2 > 1, then there exists a second threshold curve given by the function 
g('R-1) such that the boundary equilibrium Ez of (2) is l.a.s. if'R-1 < 1 or if'R-1 > 1 and 
'R-2 > g('R-1). Ez is unstable if'R-1 > 1 and 'Rz < g('R-1). Moreover g('R-1) > f('R-1) > 1 for 
all 'R-1 > 1 and g(1) = 1. 
(d). The equilibrium E* of (2) exists if 'R-1 > 1 and j('R-1) < 'R-2 < g('R-1). At 
the quasi-steady state ~Xz = %tY2 = 0, i.e., when x2 = P.J+r2 X1 and Yz = ptd,yl, the 
corresponding positive equilibrium is l.a.s. when it exists. 
The assumption q = 0 in Result 1 implies that we are considering the case where the 
resistant strain is not the result of antibiotic resistance. Result 1 states that 'R-1 and 'R-2 as 
parameters determine the existence the existences as well as the stabilities of all possible 
equilibria of (2) using the auxillary conditions 'Ro = 1, 'R,z = j('R-1), and 'R-2 = g('R-1). Fig. 
2.a gives a bifurcation diagram for the case q = 0. Our numerical simulations suggest that 
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E* is l.a.s. not only at the quasi-steady state (when the conditions in (d) are satisfied) but 
in general, and that non-trivial equilibriun points are g.a.s. whenever they are l.a.s .. 
We now consider the case q > 0, i.e., the rate at which individuals develop resistant-
TB because they did not complete the treatment of active TB is positive. In this case 
System (2) has only three equilibrium points Eo, Ez, and E*. We have established the 
following result: 
Result 2 Assume that q > 0, d = d' = 0. Then 
(i). The disease-free equilibrium Eo of (2) is g.a.s. if Ro < 1, i.e., if n 1 < 1 and 
n2 < 1. 
(ii). Ifn2 > 1, then the boundary equilibrium E2 of (2) is l.a.s. ifn1 < 1 or ifn1 > 1 
and n2 > g(nt). (g is the function given in Result 1 (c)). E2 is unstable ifn1 > 1 and 
n2 < u(nl)· 
(iii). The equilibrium E* of (2) exists iffn1 > 1 and nz < g(nl). (In this case E 2 is 
unstable). When it exists, E* is l.a.s. at the quasi-steady state ftxz = fty2 = 0, i.e., when 
k k1 X2 = ~t+d+r2 XI and Y2 = ~t+dl Y1· 
Notice that the region for existence of the stable interior equilibrium E* has changed 
from {(nil n2) 1 n1 > 1, J(n1) < n2 < u(nl)} for the case q = o to {(nr, nz) 1 n.1 > 
1, n 2 < g(n1)} for the case q > 0. Fig. 2.b gives a bifurcation diagram for the case q > 0. 
For the case when d > 0, d' > 0 our numerical simulations and bifurcation diagram also 
support similar results (see Fig. 5). 
Analysis of our model shows that non-antibiotic co-existence (for parameters corre-
sponding to (ni, 'R-2) in the region between the two curves f and g, see Fig. 2.a) is possible 
but rare for naturally resistant strains. However, for strains that result from the lack of 
compliance with antibiotic treatment by TB infected individuals co-existence (for parame-
ters corresponding to (Rr, 'R.-2) in the region below the curve g, see Fig. l.b) is almost the 
rule. 
2.2. A distributed delay model for TB. A feature of tuberculosis disease is that 
the infectious agent has evolved a "friendly" relationship with the human host as only 
a relatively small proportion of those who are infected go on to develop clinical disease. 
This is a result of probably two forces the reduction in virulence of natural strains as well 
as the evolution of a more resistant host population. Most seem to mount an effective 
immune response to the initial infection that limits proliferation of the bacilli and leads to 
long-lasting partial immunity both to further infection and to reactivation of latent bacilli 
remaining from the origional infection. The risk of disease is highest shortly after receipt of 
infection and declines thereafter. Relevant information on the development of clinical TB 
in tuberculin converters in general population can be found in the British Medical Research 
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Council's TB vaccines trial (MRC 1972) in which there were totally 243 cases among the 
participants who were initially tuberculin-negative developed the disease within 8 years. 
Observations from this study indicate that 54% had developed the disease within a year. 
29% developed during the next 3 years, and 17% during the last 4 years. This typical 
feature of TB, long and variable periods of latency, was not considered in our previous 
model as our emphasis was on the study of resistant TB. The purpose of the following 
distributed delay model is to look at the effects of variable periods of latency (rather than 
exponentially distributed) on the dynamics of TB. 
Let p( s) be a function representing the proportion of those individuals that become 
exposed at time t and that, if alive, are still infected (but not infectious) at time t + s; 
that is, they survive as infected but not infectious. Assume that 
p(s) ~ O,p(s) ~ O,p(O) = 1, 
and 100 p(s)ds < oo. 
Then the number of individuals who have been exposed from time 0 to t and are still in 
class L is given by 
Noticing that -p( r) is the rate of removal of individuals from L class into I class r units 
of time after exposed, the number of individuals who become infectious from time 0 to t 
and are still alive and in I class is 
Then we have the following model: 
d I 
dt S = A - j3cS N - p,S 
L(t) = Lo(t) + 1t f3c[S(s) + uT(s)] ~~s;)p(t- s)e-JJ.(t-s)ds 
(3) I(t) = t (r f3c[S(s) + a-T(s)] I(s) e-JJ.(r-.s)[-p(r- s)e-(JJ.+r+d)(t-r)]dsdr 
Jo Jo N(s) 
+ Ioe-(JJ.+r+d)t + Io(t) 
d I 
dtT = ri- u{3cT N- p,T 
N= S+L+I +T. 
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A is the constant recruitment rate; f3 and (J/3 denote the probability that susceptible and 
treated individuals will be infected by one infectious individual per contact per unit of 
time, 0 ~ (J ~ 1; c is the per-capita contact rate; J-l is the per-capita natural death rate; 
d is the per-capita disease-induced death rate; r is the per-capita treatment rate. L0 (t) 
denotes those individuals that were in L class at time t = 0 and are still in the latent class; 
Io(t) denotes those initially in class L who have moved into class I and are still alive at 
timet; and I0e-(J.t+r+d)t with I0 = I(O) represents those who are infectious at time 0 and 
are still alive and in the I class. Lo(t) and Io(t) are assumed to have compact support. 
If we change the order of integrations as the following, the I equation in (3) becomes 
a Volterra integral equation if we change the order of integrations as the following: 
r it f3c[S(s) + (JT(s)] I(s) e-JL(r-s)[-p(-r- s)e-CJL+r+d)(t-r)]d-rds. 
Jo s N(s) 
We note that 
= -e-(JL+r+d)(t-s) 1t-ll p( u)e(r+d)udu 
=: a(t- s). 
Therefore we can rewrite the I equation in ( 3) as 
. {t I(s) (4) I(t) = Jo a(t- s).Bc[S(s) + (JT(s)] N(s) ds + I0e-(JL+r+d)t + I0 (t). 
Results on well-posedness found in Miller (1971) guarantee the existence and uniqueness 
of solutions for System (3) as well as their continuous dependence on parameters. The 
positivity of solutions can be proved similarly to Castillo-Chavez-et al (1989). 
In the following we assume that the probability that a treated individual becomes 
infected is the same as that of a susceptible individual, i.e., we let (J = 1. Letting 
I 
W=S+T, B=.BcW N' 
System (3) with the I equation replaced by ( 4) becomes 
(5) 
.!!:_ W = A - B - uW dt ~ ' 
L(t) = L0 (t) + 1t B(s)p(t- s)e-tt(t-ll)ds, 
I(t) = Ioe-(tt+r+d)t + Io(t) + 1t a(t- s)B(s)ds, 
I(t) 
B(t) = f3cW(t) N(t). 
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The basic reproductive number in this case is given by 
where 
Let 
DL = 100 p(s)e-JL8 ds, 
then DL is the death justed mean length of the latent period. The relation between D 1 
and DL is given by 
System (5) with Lo(t) = Io(t) = Io = 0 always has the disease-free equilibrium 
A (Wo, Lo,lo) = ( -, 0, 0), 
p, 
and has no other constant solution. Since L0 (t) and J0(t) are zero for large t, and 
e-(f.l+r+d)t -t 0 as t -t oo, it could be expected that (A/ p,, 0, 0,) is an asymptotic equilib-
rium of (5) as t -too. The following results (proofs ommitted) describe our asymptotical 
results on this model. 
Result 3 IfRo :S 1, then the disease-free equilibrium (*,0,0) of the system (5) is a global 
attractor, i.e., limt-.oo(W(t), L(t), I(t)) -t (~, 0, 0) for any positive solutions of (5). 
The following result shows that when 'Ro > 1, the disease will persist in the population. 
Result 4 IfRo > 1, then the disease-free equilibrium of System (5) is unstable. Further-
more, there exists a constant fJ > 0, such that any solution (W(t), L(t),I(t)) of (5) with 
1(0) > 0 satisfies 
limsupJ(t) 2: ry. 
t->oo 
According to Miller (1971), an endemic equilibrium of the system (5), if exists, must 
satisfy the limiting system associated with (5), which is given by the following set of 
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equations: 
(6) 
d 
-W=A-B-p,W+rl dt 
L(t) = ~~ B(s)p(t- s)e-JL(t-B)ds 
J(t) = ~~ a(t- s)B(s)ds 
J(t) 
B(t) = ,BcW(t) N(t). 
Sysatem (6) has a constant solution (W*, L*, I*) with I* > 0 (an endemic equilibrium) 
given by 
where 
N* _ ARo 
- p, + ('R.o _ 1) 1-rDr • 
Dr+DL 
We have the following result about the endemic equilibrium of (6). 
Result 5 If'Ro > 1, then the limiting system (6) bas a unique endemic equilibrium which 
is locally asymptotically stable. 
Our results show that the qualitative dynamics of TB predicted by this model are 
not very different from that given by models with an exponentially distributed latency 
period. The disease either dies out or remains endemic. Nevertheless the computation of 
the basic reproductive number allows us to understand the role of different parameters in 
maintenance or eradication of TB. 
2.3. A TB model with exogenous reinfection. We note that a person infected with 
TB may develop active TB in a variety of ways. One possibility is that such a person may 
become TB active as a consequence of exogenous reinfection (i.e., acquiring a new infection 
from another infectious individual; Smith 1993). Our results from the following model 
suggest that exogenous reinfection has a drastic effect on the qualitative dynamics of TB. 
More explicitly, the incorporation of exogenous reinfection into our basic TB model allows 
for the possibility of a subcritical bifurcation at the critical value of the basic reproductive 
number ('Ro = 1) and hence, the existence of multiple endemic equilibia for Ro < 1 
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becomes a possibility. This type of behavior has been observed in recent epidemiological 
models in the context of sexually-transmitted diseases (see Hadeler and Castillo-Chavez 
1995). 
Since using a distributed delay in the removal rate from the infected class will not 
change the qualitative dynamics and will make the mathematics complicated, then we 
assume an exponential removal rate. The model with exogenous reinfection takes the 
following form: 
d I 
-S =A- {3cS-- J.LS dt N 
d I I I 
-L = {3cS-- pf3cL-- (J.L + k)L + u{3cT-dt N N N 
(7) d I dt I = p{3cL N + kL- (J.L + r +d) I 
d I 
-T = r I- u{3cT- - J.LT dt N 
N=S+L+l+T. 
The term pf3cL ~ reflects the exogenous reinfection rate. In the case where p = 0, the 
system (7) reduces to a model which produces similar results to that given by standard 
SEIR models, i.e., the disease-free equilibrium is a global attractor when 'Ro < 1 while the 
unique endemic equilibrium exists and is l.a.s. when 'Ro > 1. We assume in the following 
that p > 0. 
The basic reproductive number for (7) is given by 
'Ro _ ( {3c ) (-k-) 
- J.L+r+d J.L+k · 
Note that 'Ro does not depend on the parameter p (we assume that 'Ro is defined 
in such a way that the dominant eigenvalue of the Jacobian matrix at the disease-free 
equilibrium is greater than zero if and only if 'Ro > 1). In fact the expression of 'Ro here 
is the same as that for the case p = 0. Let 
k k 
Po= -(1+ -), 
p, J.L+r 
then we have the following result (proof ommitted). 
Result 6. (a). If'Ro > 1, then System (7) bas exactly one positive equilibrium. 
(b). If p > po, then there exists a 'Rp < 1 such that System (7) has exactly two 
positive equilibrium points E± (E:_ < E~) if and only if'Rp < 'Ro < 1. 
(c). If'R-Q < 'Rp, then the system (7) has only the disease-free equilibrium. 
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Moreover, the disease-free equilibrium is l.a.s. in the case (c), Ef. is l.a.s. and E~ is 
unstable in the case (b), and the disease-free equilibrium is unstable while the endemic 
equilibrium is l.a.s. in the case (a). 
Result 6 indicates that for each fixed p > Po there is a branch of endemic equilibria 
bifurcating (backwards) from the disease-free equilibrium at 'R<J = 1, and hence the system 
(7) has multiple equilibria for 'R<J < 1. The bifurcation diagram is shown in Fig. 6. 
2.4. An age-structrued TB model. Because TB is a communicable disease primarily 
spread by the airborne route, the risk of an uninfected person becoming infected is strongly 
associate with the probability of coming in contact with an infectious individual and the 
duration of that contact (Reichman 1993). There are evidences showing that TB case 
rates are highly age-dependent. It is clear that mixing plays a key role in TB transmission. 
To look at the effects of age-dependent contact rates on TB dynamics and to look for 
optimal ages for vaccination, we formulate an age-structured model which we study in two 
cases: 1) in the absence of a vaccine and 2) with an age-dependent vaccination rate. Let 
s(t, a), l(t, a), i(t, a) and j(t, a) be density functions in the respective classes. Assume that 
all newborns are susceptible, that the mixing is proportional, and that the disease-induced 
death rate can be neglected. Then in the absence of vaccination the dynamics of the classes 
are governed by the following initial boundary value problem: 
(8) 
8 8 ( 8t + 8a)s(t,a) = -c(a)B(t)s(t,a)- p.s(t,a), 
(:t + :a)l(t, a) = c(a)B(t)s(t, a) - (k + p.)l(t, a) + crc(a)B(t)j(t, a), 
(:t+ :a)i(t,a) =kl(t,a)- (r+J.L)i(t,a), 
(:t + :a)j(t, a) = ri(t, a)- uc(a)B(t)j(t, a)- J.Lj(t, a), () 100 i(t,a') f3 ( ') 1 B t = ( ') p t, a, a da , 
0 n t,a 
, c(a')n(t, a') 
p(t, a, a) = J000 c( u)n(t, u)du' 
s(t, 0) =A, l(t, 0) = i(t, 0) = j(t, 0) = 0, 
s(O, a) =so( a), l(O, a)= lo(a), i(O, a) = io(a), j(O, a) = jo(a), 
n(t,a) = s(t,a) + l(t,a) +i(t,a) + j(t,a), 
where A is the recruitment rate; f3 is the probability that a susceptible individual becomes 
infected by one infectious individual per contact per unit of time; c( a) is the age-specific 
per-capita contact rate; J.L, k and r are as before; p( t, a, a) gives the probability that a 
contact takes place between a susceptible of age a and an infectious individual of age a at 
timet given that a contact has taken place. 
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We use the method of "next generation operator" developed by Diekmann et al (1990) 
(also see Heesterbeek (1992)) to calculate the basic reproductive number Rn for (8). Fol-
lowing Diekmann (1992) we let S(a) denote the density function describing the steady 
demographic state in the absence of the disease, and define A(T, a, a) to be the expected 
infectivity of an individual which was infected T units of time ago while at age a towards 
an uninfected individual of age a at the steady demographic state. The function A( T, a, a) 
combines information on the probability (per unit of time) that contacts between certain 
ages take place and the probability that, given a contact, the disease agent is actually 
transmitted. Then under the special assumption of proportionate-mixing A(T, a, a) can 
be written in the form A(T,a,a) = f(a)g(T,a). 
Lemma 7. (Diekmann) Under assumptions above, no is given by tbe formula 
Now we use the Lemma 7 to calculate no for System (8). Consider a demographic 
steady state (s(a), 0, 0, 0) of System (8) with every one susceptible and ignore the fact that 
S(a) decreases due to the infection process (see Diekmann (1992)). Then s(a) = n(a) = 
Ae-JUL. Since we are assuming proportionate mixing we have that 
p(a) = 00 c(a)n(a) . f0 c(u)n(u)du 
Let 'Y( T, a) be the probability that an individual of age a+T who was infected T time units 
ago is in class i. Let u E (0, T), then the probability that an individual of age a+ T who 
was infected T time units ago is in class l at time u after infection (probability of remaining 
in l class times probability of still alive at age a+ u given alive at age a) is given by 
The density function for entering class i is therefore 
(9) 
In order to be in the class i with infection age T one should 
i) have entered i at some time u E (0, T) 
ii) have remained in i in the interval ( u, T). 
The probability that ii) holds is 
(10) 
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Then from (9) and (10) we have 
'Y(T, a) = 17 ke-(JL+k)ue-(r+JL)(T-u)du 
k ( -kT -rT) -jl.T 
= -- e -e e . 
r-k 
It is easy to check that 'Y(T, a) > 0 for all r > 0, k > 0. By the definition of A(r, a, a) 
we have 
'Y(T,a) 
A(r, a, a)= ,B(a)c(a)p(a + r) ( ) 
n a+T 
k 1 
= ,B(a)c(a)p(a + T)--(e-kT- e-r7 )eJLC<-
r-k A 
=: f(a)g(r,a), 
where 
f(a) = ,B(a)c(a), 
k 1 
g(T, a)= p(a + T) r _ k (e-kT- e-r7 )eJLC< A 
Noticing that s(a) = Ae-J.Wt. we get by Lemma 7 that 
(11) 1()()100 k no= ,Bc(a)p(a + T)--k(e-kT- e-rT)dTdO:. 
o o r-
We can now state the following result (proof ommitted) 
Result 8: (a) The disease-free equilibrium of System (8) is stable ifRo < 1 and unstable 
ifno > 1. (b) When no> 1, there exists an endemic steady state age distribution. 
The formula (11) for no can be used to formulate optimaization problems related to 
vaccination strategies for TB as stated in the following. 
We assume next that susceptibles in the same age-structured population are vaccinated 
at an age-dependent vaccination rate 'lj;(a) (similar results can be obtained in the case where 
susceptible can not be recognized and thus every one will be vaccinated (see Hadeler)). 
We also assume that vaccination lasts. Let R( 'lj;) be the basic reproduction number in 
the presence of the vaccination strategy 'lj;. Note that for the calculation of R( 'ljJ) we only 
need to consider the equation for s since the population is assumed to be at demographic 
equilibrium consisting of pure susceptible. The equation for sin (8) now has the following 
form: 8 8 (8t + 8a)s(t,a) = -c(a)B(t)s(t,a)- p,s(t,a)- 'lj;(a)s(t,a). 
Let s'I/J (a) denote the density function describing the steady demographic state in the 
absence of disease, and let 
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Then 
Similarly to the derivation of the the formula for 'RQ, we obtain the following expression 
for R('¢): 
100100 k R('¢) = /Jc(a)p(a + r) --k (e-kT- e-rT):Fv(a)drda. o o r-
Since '1/J(a) 2: 0, we have 
R('¢) ~ Ro, R(O) = Ro, 
and the representation 
R('¢) = Ro + F('¢), 
where 100100 k . F('¢) = /Jc(a)p(a + r)--k(e-kT- e-r7 )(1- :Fv(a))drda. 
. o o r-
Remark: The quantity F( 'ljJ) is tbe reduction in tbe reproductive number tbat can be 
achieved by applying tbe vaccination strategy 'ljJ. 
In the case when Ro > 1, one would like to choose a vaccination strategy 'lj; which 
makes F( 'if;) large, and thus possibly reduces R( 'if;) to values below 1 and leads to the 
elimination of the disease. In Dietz and Schenzle (1985) a simpler formula is derived which 
can be used to compute cp(a) to reduce R(cp) below 1 in cases where infectious periods are 
short. Because of the long and variable periods of infectiousness in the case of TB, we will 
consider the equivalent problems to those proposed in Hadeler (1993) for IDV. 
In practice the application of vaccination strategies is limited by costs. We assume 
that the expenses of one vaccination at age a are given by a positive number K(a), and 
that the total cost depends linearly on the number of vaccinations (see Hadeler). Note 
that vaccination here means a transition from the susceptible state to the vaccinated state. 
Applications of vaccine which do not lead to a vaccination are incorporated into the cost 
function K. Let 0( 'if;) be the total cost of the vaccination strategy '1/;, then 
0('1/;) = 100 K(a)'if;(a)s.p(a)da, 
where s.p(a) is given by (11). Now we can define the following optimization problems. 
(I) Find a vaccination strategy '1/J(a) that minimizes C('¢) constrained by R('¢) ~ R*. 
(II) Find a vaccination strategy '1/J(a) that minimizes R('I/J) constrained by C('lj;) ~ K*. 
Notice that 
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To make both C('ljJ) and F('ljJ) linear functionals we apply the following transformation 
qy( a) = -:a efo" !f;(s)ds = '1/J( a)e- fo" 1/J(s)ds. 
Denote F(¢J) = F('ljJ), C(qy) = C('ljJ). Then noticing that 
1- :F('ljJ) = 1- e- foa1/J(s)ds =La qy(s)ds, 
and also noticing that (by exchanging the order of integrations) 
we arrive at 
where 
Let 
F(¢) = 100 K(a)qy(a)da, 
C(qy) = 100 B(a)qy(a)da, 
. 100 roo k K(a) = a Jo ,Bc(a)p(a + 7) r _ k (e-kT- e-rr)dTda, 
B(a) = AK.(a)e-JUJ.. 
Q(qy) = 100 ¢(a)da, 
it is easy to see that Q(qy) :::; 1. Let p =Ro-n*, then the problem (I) can be written as: 
where 
(12) 
Minimize C(¢) 
f(qy) :::; 0, 
¢J ?_ 0, 
subject to 
!(¢) = (/1(¢)) = (P_-F(¢J)) 
h(¢) C(¢)- 1 ' 
and f(qy):::; 0 is equivalent to fi(¢J):::; 0 (i = 1,2). 
Analysis of the optimization problem (12) leads us to the following result (pfoof om-
mitted). 
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Result 9: In a generic situation the optimal vaccination strategy in problem (I) is either 
a one-age strategy with vaccination at exactly one age A, or it is a two-age strategy 
where part of the population is vaccinated at an age A1 and all remaining susceptible are 
vaccinated at a later age A2. 
For the explanation of the word "generic" see Hadeler. A similar conclusion for prob-
lem (II) can be obtained, i.e., the optimal vaccination strategy is either a one-age strategy 
or a two-age strategy. 
Remark Formulas can be derived to calculate the corresponding total costs and to find 
the optimal ages for these two vaccination strategies. 
3. Numerical simulations. In this section we study the system (1) and (2) numerically 
to confirm our analytical results as well as to provide evidences that our results are likely 
to hold in more general situations. First we "extend" the result of Result 1 (d) numerically. 
Our simulations· support the stability of the interior equilibrium E3 for the system (2) 
not only at· the quasi-steady state but in general (see Fig. 3). Fig. 3 presents some 
phase portraits for the system (2) which show that (for parameters in certain region (see 
Fig. 2)) the corresponding l.a.s. equilibrium (E1,E2 and E*) attracts all solutions with 
positive initial data. Similar simulations have been carried out when q > 0 to support the 
same conclusion (see Result 2) that the interior equilibrium E* is asymptotically stable 
whenever it exists not only at the quasi-steady state but in general, and that the non-trivial 
equilibrium points switch stability as the parameters change as specified in the bifurcation 
diagram (see Fig. 2.b and Fig. 4). We also "extend" the results of Result 2 numerically 
to the case when d > 0 and d' > 0. This is done by establishing a functional relationship 
between f3 and /3' and by showing numerically that this function plays a role similar to 
that of the function gin Result 2 (see Fig. 5). 
For the construction of Fig. 3 we have selected for illustration purposes the following 
parameter values: J-l = 0.0143 (1/ f-t = 70 years), {3 = 13, c = 1, k = 1, q = O,p = 0.5, r 1 = 
1, r 2 = 2, k' = 1, A = 35, d = d' = 0. This choice of parameter values gives R 1 = 3.45. By 
calculating the formulas for f(RI) and g(RI) we get 
(R1, R2) E III iff 1.34 < R2 < 4.13, 
(R1, R2) E II iff 'R2 > 4.13, 
(R1, R2) E IV iff R2 < 1.34. 
The value of R 2 for Fig. 3.a is chosen to be 2. Our simulations show that E* attracts all 
solutions with positive initial data. Values of R2 for Fig. 3.b and Fig. 3.c are 4.5 and 1.2, 
and our simulations support the global stabilities of E 1 and E2 , respectively. 
Fig. 4 is for the case when q > 0, and d = d' = 0. The parameter values used in Fig. 
4 are k = 0.5, k' = 1, f-t = 0.0143, q = 0.01,p = 0.4, r1 = 2, r2 = 1, d = 0, d' = 0, A = 500. 
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{3 is chosen to be 13 as it corresponds to R1 = 2.627 and R 2 = g(Ri) = 2.7364. This last 
selection implies that Ez is l.a.s. if Rz > 2. 7364 and it also implies that E* exists and 
is l.a.s. if R 2 < 2.7364. In Fig. 4, the values for R 2 are chosen to be (a) R 2 = 0.9, (b) 
Rz = 1.5, (c) Rz = 2, and (d) Rz = 3. 
Our analytic results for the stabilities of equilibrira Ez and E* (see Result 2) hold only 
for d = 0 and d' = 0. Since the death rate d' from resistant-TB may be high, one would 
like to know if similar results hold when d > 0 and d' > 0. Our numerical simulations 
suggest that this is the case (see Fig. 5). The parameter values used in Fig. 5 are the 
same as those used in Fig. 4 except that d = 0.1 and d' = 0.5. By choosing {3 = 13 
(corresponding to 'R-1 = 2.39) and by calculating Rz = g(R1) = 2.139 we conclude that E2 
is l.a.s. if 'Rz > 2.139 and E* exists and is l.a.s. if Rz > 2.139. In Fig. 5 the values for 'R-2 
are chosen to be (a) 'R-2 = 0.9, (b) R2 = 1.5, (c) 'R-2 = 2, and (d) 'R-2 = 3. 
4. Conclusion.· In this paper we introduced a series of models to study the dynam-
ics of TB. We discuss a two-strain model for TB and resistant TB with the purpose of 
determining the role that lack of drug treatment compliance by TB patient plays on the 
maintenance of antibiotic resistant strain (for details see Castillo-Chavez and Feng, 1995). 
To make the role of antibiotic resistance transparent, we first studied a special version of 
our two-strain model with two competing strains of TB: the typical strain plus a resistant 
strain that was not the result of antibiotic resistance. In the last situation, We found that 
co-existence is possible but rare while later we noticed that co-existence is almost cert"ai.n 
when the second strain is the result of antibiotic resistance. 
To study the effects of long and variable periods of latency on the dynamics of TB we 
constructed a TB model with distributed delay (see Castillo-Chavez and Feng, 1996a). We 
found that the qualitative dynamics of TB predicted by this model is not very different 
from that given by a corresponding model with an exponentially distributed latency period. 
Qualitative behaviors change only at a critical value no = 1, i.e., if no < 1 then an unique 
equilibrium (the disease-free equilibrium) exists and is g.a.s., while if no > 1 then the 
disease-free equilibrium is unstable and there exists an unique endemic equilibrium which 
is l.a.s .. 
Relatively drastic changes of qualitative behaviors of the disease dynamics occur when 
the effect of exogenous reinfection is incorporated into the model (see Castillo-Chavez and 
Feng, 1996b). Our results suggest that the introduction of exogenous reinfection into the 
basic TB model allows for the possibility of a subcritical bifurcation of endemic equilibrium 
points at the critical value of the basic reproductive number R.o = 1, and hence the 
existence of multiple endemic equilibria for no < 1. 
We also constructed an age-structured TB model to look at optimal vaccination strat-
egy problems (see Castillo-Chavez and Feng, 1996c). Under the assumption of proportion-
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ate mixing we calculated the basic reproductive number which were used to study cost 
related optimization problems. We found that the optimal vaccination strategies have the 
form of one-age strategies or of two-age strategies. 
It has been suggested that the emergence of the lllV epidemic has dramatically in-
creased the risk of developing clinical TB in infected persons, substantially increasing TB 
rates globally (Miller (1993)). The evidence though seems weak. Immigration from coun-
tries with higher TB prevalence to the United States has always contributed to the dramatic 
increases in the incidence of TB within USA particularly over the past few decades. Here 
we have introduced a few models to illustrate how we can address a- of questions that 
are important in our understanding of TB dynamics. 
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Fig.2.a. A bifurcation diagram for the system (2.5) in the case 
q = 0. There are four regions I, II, III, and IV in the parameter 
space (R1, R2). In the region I E1 is a global atractor and other 
equilibria a_re unstable when they exist. In regions IT and IV E3 
does not exist and E2 and E4 are l.a.s., respectively. In the region 
ill E3 exists and is l.a.s .. 
Fig.2.b. A bifurcation diagram for the system (2.5) in the case 
q > 0. There are three regions I, II and III in the parameter space 
(R17 R 2) (E4 does not exist.), and they correspond to stabilities of 
E1, E2, and Ea, respectively. 
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Fig.3. Phase portraits of solutions 
to (2.5) . Parameter values for all three 
graphs are chosen to be: J.L = 0.0143, f3 = 
13,c = l,k = l,q = O,p = 0.5,rl = 
l,r2 = 2,k' = l,A = 35,d = d' = 0. 
This choice of parameters give a fixed 
value nl = 3.45. In (a) R 2 = 2 and 
hence (R1, Rz) EIII. In (b) R 2 = 4.5 and 
hence (Rt, R2) ElL In (c) R 2 = 1.2 and 
(R1, R2) EIV. Circle "0" indicates a 
stable equilibrium and triangle "h." indi-
cates an unstable equilibrium. (Graphs 
are given by Phsplan). 
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Fig.4. Plots of fractions of infected and infectious population 
versus time in the case q > 0, d = d' = 0. Parameters for all graphs 
are chosen to be: J..L = 0.143, {3 = 13, c = 1, k = 0.5, q = O.Ol,p = 
0.4, r1 = 2, r2 = 1, k' = 1, A = 500, d = d' = 0. 
In (a) 'R-2 = 0.9 and hence ('Rb 'Rz) E III. In (b) 'R-2 = 1.5 
and ('R-11 'R-2) E III. In (c) 'R-2 = 2 and ('Rl> 'R-2) E III. In {d) 
'R-2 = 3 and ('Rt, 'R-2) E IV. 
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Fig.5. Plots of fractions of infected and infectious population 
versus time in the case q > 0, d > 0, d' > 0. Parameters for all 
graphs are chosen to be: JL = 0.143, {3 = 13, c = 1, k = 0.5, q = 
O.Ol,p = OA,r1 = 2,r2 = l,k' = 1,A = 500,d = 0.1,d' = 0.5. 
In (a) R2 = 0.9 and hence (Rt, R2) E III. In (b) R2 = 1.5 
and (R1, R2) E III. In (c) R2 = 2 and (R1. R2) E. III. In (d) 
R2 = 3 and (R1, R2) E IV. 
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